PHILADELPHIA, April 16 /PRNewswire-FirstCall/ -- AVVAA World Health Care Products, Inc. (BULLETIN BOARD: AVVW) , a biotech company offering therapeutic, all natural skin and health care products has proposed collaboration with Philadelphia’s St. Agnes Medical Center and Drexel University College of Medicine’s Radiation Oncology Department to conduct clinical trials to further define the benefits of NEUROSKIN spray for the different kinds of burns.
Dr. Mark Alden, V.P. Research and Development for AVVAA states, “Over the past decade of experience with NEUROSKIN spray, the department of Research and Development has received numerous reports from individuals who have come forward telling of amazing relief from pain and rapid recovery from thermal burns and sunburn after applying NEUROSKIN spray. We have accumulated personal experience with this application, as well as in patients with radiation burns. No toxicity or adverse events have been seen, and the relief and rapid recovery have been confirmed. These exciting results have led AVVAA to propose collaboration with physicians at the St. Agnes Burn Center and at Drexel University College of Medicine’s Radiation Oncology Department to conduct clinical trials to further define the benefits of NEUROSKIN spray for the different kinds of burns.”
The hallmark of St. Agnes’ Medical Center is the Center for Advanced Burn & Wound Care which is the first hospital unit of its kind in Philadelphia and one of 67 burn centers in the U.S. to be awarded verification by the prestigious American Burn Association and the American College of Surgeons. This significant distinction is awarded to the Center for its ongoing commitment to burn care excellence and rendering of high-quality treatment to burn and wound patients.
About AVVAA World Health Care Products
AVVAA World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. AVVAA’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. AVVAA is poised to manufacture and market its O-T-C NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.
The Company’s newly-acquired subsidiary, Mystic Mountain Body and Spa Products, is a Canadian company that recently agreed to form a joint venture with a Canadian First Nations Band, to develop, manufacture and distribute superior quality bath, body and spa products in the region.
For more information, visit: http://www.avvaa.com/ or http://www.otcfn.com/avvw . Contact: West Coast Investor Relations: Merle Goertz Geoffrey Eiten (604) 688-2349 OTC Financial Network (781) 444-6100 x613
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
AVVAA World Health Care Products, Inc.
CONTACT: West Coast: Merle Goertz, +1-604-688-2349; or InvestorRelations: Geoffrey Eiten of OTC Financial Network, +1-781-444-6100 ext. 613,both for AVVAA World Health Care Products, Inc.
